The system called IRIDICA could change how doctors fight infectious diseases.
The origins of IRIDICA can be traced back to the mid-1990s, when researchers including Dave Ecker were working at a company called Isis Pharmaceuticals.
"Everyone was asking the wrong questions, taking existing technology and making individual tests for diseases. But with over 1,000 organisms causing disease in humans, you can't make 1,000 tests," said Ecker, who is now the divisional vice president of R&D for Abbott's Ibis Biosciences business.
In 2000, the group came up with the concept that would ultimately become IRIDICA: a universal pathogen detector that could detect disease directly from specimens, like blood or tissue, fastcoexist.Com reported.
Genetic material (some belonging to the sick human, some belonging to the pathogen) is extracted.
Copies of the pathogen's genetic material are created. Then, that material goes into a device called a mass spectrometer to figure out the molecular weight of the pathogen.
The platform can diagnose all types of bacterial, fungal, and viral infections, and can also quickly figure out the specific organism causing a patient's sepsis - an infection that can kill within 15 hours, researchers said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
